CLINUVEL (CUV) is a pharmaceutical group focused on developing and commercialising treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialised populations. As pioneers in photo medicine and the family of melanocortin peptides
Find out what a historical investment in Clinuvel Pharmaceuticals would be worth today using our CUV stock calculator.
Buying CUV shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Clinuvel Pharmaceuticals in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CUV
What is the ticker symbol of Clinuvel Pharmaceuticals?
The ticker symbol for Clinuvel Pharmaceuticals is CUV.
How much is one share of CUV?
One share of CUV is valued at $7.15 as of 22 November 2026.
What is the market capitalisation of Clinuvel Pharmaceuticals CUV?
As of 22 November 2026 Clinuvel Pharmaceuticals has a market cap of $365.53M.
Does CUV pay dividends?
Yes, CUV does pay dividends.
What is the dividend yield for CUV?
The dividend yield for CUV is 0.69% as of 22 November 2026.
How much dividends does CUV pay?
The most recent CUV dividend distribution paid $0.05 per share on 18 September 2026.
What is the CUV ex-dividend date?
The ex-dividend date of CUV was 03 September 2026.
What is the P/E ratio of CUV?
The Price to Earnings ratio of CUV is 10.84.
What is the Earnings Per Share of CUV?
The Earnings Per Share of CUV is $0.67.
What is the 52-week high for Clinuvel Pharmaceuticals stock?
The Clinuvel Pharmaceuticals 52-week high stock price is $13.48.
What is the 52-week low for Clinuvel Pharmaceuticals stock?
The Clinuvel Pharmaceuticals 52-week low stock price is $6.62.
Can I buy CUV shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CUV shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.